Arvaya Healthcare Q2 FY27 Consolidated Financial Results and Strategic Updates
Bijoy Hans Ltd · Financial Result · 14 Nov 2026, 1:04 am
Arvaya Healthcare Q2 FY27 Consolidated Financial Results and Strategic Updates Arvaya Healthcare reported Q2 ended 30th Sep'26 consolidated revenue of ₹40.28 cr (vs ₹29.91 cr in Q1) and net profit of ₹1.37 cr (vs ₹0.53 cr in Q1). Standalone Q2 revenue was ₹0.91 cr with a net loss of ₹0.46 cr. Post-quarter on 1st Nov'26, the company completed the 100% acquisition of Sushodha Institute of Gastroenterology via a share swap, allotting 38.72 lakh equity shares on 24th Oct'26. Additionally, the board progressed a proposed rights issue of partly paid-up equity shares aggregating up to ₹210 cr.
Original exchange filing (PDF)
More announcements from Bijoy Hans Ltd
- The investor call arranged by the company on 16th November,2026 was concluded successfully. Please find attached herewith Audio for the same. · 17 Nov 2026
- Investor Presentation in relation with the Unaudited Standalone and consolidated Financial Results of the Company for the quarter and half year ended on September 30 2026 and overall company .... · 16 Nov 2026
- Statement of Deviation and Variation for the quarter ended 30th September 2026 is not applicable to the Company. · 14 Nov 2026
- Declaration of Unaudited standalone and consolidated Financial Results for the half year ended and 2nd quarter ended 30th September 2026 · 14 Nov 2026
- Revision in intimation and In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Arvaya Healthcare Limited (formerly known .... · 16 Nov 2026
- In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Arvaya Healthcare Limited (formerly known as Bijoy Hans Limited) (''the .... · 16 Nov 2026
- Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Pursuant to the provisions .... · 13 Nov 2026
- Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 , the committee has approved and adopted the Draft Letter of Offer. · 07 Nov 2026
